![Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). - Abstract - Europe PMC Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). - Abstract - Europe PMC](https://europepmc.org/articles/PMC4689180/bin/cir-132-2403-g008.jpg)
Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). - Abstract - Europe PMC
![Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data - Didden - 2023 - Pulmonary Circulation - Wiley Online Library Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data - Didden - 2023 - Pulmonary Circulation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/586f192a-a449-4047-b85b-b060e0b55db8/pul2.v13.1.cover.jpg?trick=1675856950978)
Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data - Didden - 2023 - Pulmonary Circulation - Wiley Online Library
Biomarker counselling, disclosure of diagnosis and follow‐up in patients with mild cognitive impairment: A European Alzheimer
![G-Protein Biased Mu-Opioid Receptor Ligands for Chronic Pain Management (Oliceridine, Olinvyk, Trevena, Review) G-Protein Biased Mu-Opioid Receptor Ligands for Chronic Pain Management (Oliceridine, Olinvyk, Trevena, Review)](https://images.ctfassets.net/59984t4qg9dz/ppm_wysiwyg_fid10816_asset/d9ded020ea4ab84d5b8614e5638feeca/Screen_Shot_2019-02-28_at_11.29.34_AM.png?fm=webp&fit=thumb&q=65&w=328&h=510)
G-Protein Biased Mu-Opioid Receptor Ligands for Chronic Pain Management (Oliceridine, Olinvyk, Trevena, Review)
Jenny A. Petersen - Director, Clinical Trial Disclosure and Transparency - Alnylam Pharmaceuticals | LinkedIn
![Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia - Kleineidam - Alzheimer's & Dementia - Wiley Online Library Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia - Kleineidam - Alzheimer's & Dementia - Wiley Online Library](https://alz-journals.onlinelibrary.wiley.com/cms/asset/a97b6d18-8c18-4b29-b411-887a96e5e632/alz12785-fig-0002-m.jpg)
Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia - Kleineidam - Alzheimer's & Dementia - Wiley Online Library
![Frontiers | Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions Frontiers | Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions](https://www.frontiersin.org/files/Articles/1052386/falgy-04-1052386-HTML-r1/image_m/falgy-04-1052386-g001.jpg)
Frontiers | Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions
![Niemann-Pick type C disease: Journey to diagnosis Slide set for [INSERT SPECIALITY] [INSERT DATE] This survey was sponsored by Actelion Pharmaceuticals. - ppt download Niemann-Pick type C disease: Journey to diagnosis Slide set for [INSERT SPECIALITY] [INSERT DATE] This survey was sponsored by Actelion Pharmaceuticals. - ppt download](https://slideplayer.com/7601673/25/images/slide_1.jpg)
Niemann-Pick type C disease: Journey to diagnosis Slide set for [INSERT SPECIALITY] [INSERT DATE] This survey was sponsored by Actelion Pharmaceuticals. - ppt download
![Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years | Scientific Reports Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-55213-8/MediaObjects/41598_2019_55213_Fig1_HTML.png)